The article highlights three blue chip stocks recommended for long-term investment: Microsoft, which is currently undervalued and offers growth potential; Becton, Dickinson, a stable medical supply company with a strong dividend history; and Clorox, known for its consumer brands and a high dividend yield, despite recent challenges. These stocks are suggested as less volatile alternatives to growth stocks, providing both stability and income.
Microsoft's current valuation presents a compelling opportunity, as it is trading at a forward P/E ratio of 22, significantly below its five-year average of 30, making it the cheapest since 2019. This discount, coupled with its diversified business model and growing dividend, suggests a strategic investment opportunity for long-term portfolio growth and stability.